Federal Circuit partly remands Duke University and BioMarin dispute

27-04-2017

Federal Circuit partly remands Duke University and BioMarin dispute

brianajackson / iStockphoto.com

The US Court of Appeals for the Federal Circuit has partly affirmed, partly reversed and partly vacated a dispute between Duke University, based in North Carolina, and biotech company BioMarin Pharmaceutical.


US Court of Appeals for the Federal Circuit, PTAB, Duke University, BioMarin, patent, USPTO, Pompe disease, patent infringement

LSIPR